ATE156015T1 - Arzneimittel zur behandlung von vulva-dystrophie oder vaginaltrockenheit - Google Patents

Arzneimittel zur behandlung von vulva-dystrophie oder vaginaltrockenheit

Info

Publication number: ATE156015T1
Authority: AT; Austria
Prior art keywords: treatment; dystrophy; vulva; vaginal dryness; medicinal products
Prior art date: 1992-05-27

Application number

AT93303863T

Other languages

English (en)

Inventor

David Frederick Horrobin

Original Assignee

Scotia Holdings Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-05-27

Filing date

1993-05-19

Publication date

1997-08-15

1993-05-19 Application filed by Scotia Holdings Plc filed Critical Scotia Holdings Plc

1997-08-15 Application granted granted Critical

1997-08-15 Publication of ATE156015T1 publication Critical patent/ATE156015T1/de

Links

206010047791 Vulvovaginal dryness Diseases 0.000 title abstract 2
229940126601 medicinal product Drugs 0.000 title 1
210000003905 vulva Anatomy 0.000 title 1
HOBAELRKJCKHQD-UHFFFAOYSA-N (8Z,11Z,14Z)-8,11,14-eicosatrienoic acid Natural products CCCCCC=CCC=CCC=CCCCCCCC(O)=O HOBAELRKJCKHQD-UHFFFAOYSA-N 0.000 abstract 3
235000021298 Dihomo-γ-linolenic acid Nutrition 0.000 abstract 3
HOBAELRKJCKHQD-QNEBEIHSSA-N dihomo-γ-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HOBAELRKJCKHQD-QNEBEIHSSA-N 0.000 abstract 3
235000004626 essential fatty acids Nutrition 0.000 abstract 1
201000006669 vulvar dystrophy Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Fats And Perfumes (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Orthopedics, Nursing, And Contraception (AREA)

AT93303863T 1992-05-27 1993-05-19 Arzneimittel zur behandlung von vulva-dystrophie oder vaginaltrockenheit ATE156015T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB929211229A GB9211229D0 (en)	1992-05-27	1992-05-27	Fatty acid treatment

Publications (1)

Publication Number	Publication Date
ATE156015T1 true ATE156015T1 (de)	1997-08-15

Family

ID=10716100

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT93303863T ATE156015T1 (de)	1992-05-27	1993-05-19	Arzneimittel zur behandlung von vulva-dystrophie oder vaginaltrockenheit

Country Status (15)

Country	Link
US (1)	US5380757A (de)
EP (1)	EP0572159B1 (de)
JP (1)	JPH0640903A (de)
AT (1)	ATE156015T1 (de)
AU (1)	AU660223B2 (de)
CA (1)	CA2096556A1 (de)
DE (1)	DE69312579T2 (de)
DK (1)	DK0572159T3 (de)
ES (1)	ES2107622T3 (de)
GB (1)	GB9211229D0 (de)
GR (1)	GR3025178T3 (de)
NO (1)	NO931923L (de)
NZ (1)	NZ247660A (de)
TW (1)	TW336171B (de)
ZA (1)	ZA933469B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ280017A (en) *	1994-09-21	1997-06-24	Scotia Holdings Plc	Use of n-6 or n-3 series essential fatty acid (efa), and optionally an oestrogen, to make a medicament to treat or prevent hormone replacement therapy (hrt) associated breast pain in peri- or postmenopausal women; medicaments containing the efa and estrogen.
US5897880A (en)	1995-09-29	1999-04-27	Lam Pharmaceuticals, Llc.	Topical drug preparations
US6387407B1 (en)	1995-09-29	2002-05-14	L.A.M. Pharmaceutical Corporation	Topical drug preparations
US6036977A (en) *	1995-09-29	2000-03-14	L.A.M. Pharmaceutical Corp.	Drug preparations for treating sexual dysfunction
US6251436B1 (en)	1995-09-29	2001-06-26	L.A.M. Pharmaceutical Corporation	Drug preparations for treating sexual dysfunction
US20050065161A1 (en) *	1996-02-02	2005-03-24	Nitromed, Inc.	Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
US6472425B1 (en)	1997-10-31	2002-10-29	Nitromed, Inc.	Methods for treating female sexual dysfunctions
US6479545B1 (en) *	1999-09-30	2002-11-12	Drugtech Corporation	Formulation for menopausal women
AU6124401A (en) *	2000-05-09	2001-11-20	Nitromed Inc	Infrared thermography and methods of use
ATE369868T1 (de) *	2000-06-27	2007-09-15	Qualilife Pharmaceuticals Inc	Zusammensetzungen und verfahren zur behandlung der weiblichen sexuellen reaktion
US20020172712A1 (en) *	2001-03-19	2002-11-21	Alan Drizen	Antiemetic, anti-motion sustained release drug delivery system
US20030138494A1 (en) *	2001-05-15	2003-07-24	L.A.M. Pharmaceutical Corporation	Drug preparations for treating sexual dysfunction
AU2003221715A1 (en) *	2002-06-14	2003-12-31	Alcon, Inc.	Use of hydroxyeicosatetraenoic acid compounds to treat vaginal dryness
CA2436650A1 (en) *	2003-08-06	2005-02-06	Naturia Inc.	Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses
US9078845B2 (en) *	2005-01-20	2015-07-14	Kayban Pty Ltd	Anti-microbial agent
CA2704371A1 (en) *	2007-11-01	2009-05-07	Wake Forest University School Of Medicine	Compositions and methods for prevention and treatment of mammalian diseases
US8343753B2 (en) *	2007-11-01	2013-01-01	Wake Forest University School Of Medicine	Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
GB0907413D0 (en)	2009-04-29	2009-06-10	Equateq Ltd	Novel methods
US20110159074A1 (en) *	2009-12-30	2011-06-30	Raphael Warren	Wipe Article Comprising Lotion Composition Comprising Omega-6 Fatty Acid And Method Of Improving Skin Barrier Function
CA2784031A1 (en) *	2009-12-30	2011-07-07	The Procter & Gamble Company	Absorbent article comprising lotion composition comprising omega-6 fatty acid
US20120083747A1 (en) *	2010-10-01	2012-04-05	Leo Galland	Vaginal renewal complex and applicator
US8293790B2 (en)	2011-10-19	2012-10-23	Dignity Sciences Limited	Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
MX375328B (es)	2014-06-04	2025-03-06	Ds Biopharma Ltd	Composiciones farmacéuticas que comprenden ácido dihomo-gamma-linolénico (dgla) y uso de las mismas
US20210315851A1 (en)	2020-04-03	2021-10-14	Afimmune Limited	Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5145686A (en) *	1982-02-03	1992-09-08	Efamol Limited	Topical pharmaceutical compositions
AU556817B2 (en) *	1982-02-03	1986-11-20	Efamol Limited	Topical application of a lithium salt and dihomo-alpha- linolenic acid
GB8302708D0 (en) *	1983-02-01	1983-03-02	Efamol Ltd	Pharmaceutical and dietary composition
US5059622A (en) *	1989-08-29	1991-10-22	Biosyn, Inc.	Method for reducing blood pressure levels in hypertensive persons
GB9116054D0 (en) *	1991-07-24	1991-09-11	Efamol Holdings	Preparation of fatty acid medicaments

1992
- 1992-05-27 GB GB929211229A patent/GB9211229D0/en active Pending
1993
- 1993-05-14 US US08/061,110 patent/US5380757A/en not_active Expired - Fee Related
- 1993-05-18 AU AU38611/93A patent/AU660223B2/en not_active Ceased
- 1993-05-18 ZA ZA933469A patent/ZA933469B/xx unknown
- 1993-05-19 AT AT93303863T patent/ATE156015T1/de not_active IP Right Cessation
- 1993-05-19 DK DK93303863.0T patent/DK0572159T3/da active
- 1993-05-19 EP EP93303863A patent/EP0572159B1/de not_active Expired - Lifetime
- 1993-05-19 ES ES93303863T patent/ES2107622T3/es not_active Expired - Lifetime
- 1993-05-19 CA CA002096556A patent/CA2096556A1/en not_active Abandoned
- 1993-05-19 DE DE69312579T patent/DE69312579T2/de not_active Expired - Fee Related
- 1993-05-20 JP JP5118545A patent/JPH0640903A/ja active Pending
- 1993-05-20 NZ NZ247660A patent/NZ247660A/en unknown
- 1993-05-26 NO NO931923A patent/NO931923L/no unknown
- 1993-05-27 TW TW082104211A patent/TW336171B/zh active
1997
- 1997-10-29 GR GR970402813T patent/GR3025178T3/el unknown

Also Published As

Publication number	Publication date
GB9211229D0 (en)	1992-07-08
NZ247660A (en)	1997-06-24
EP0572159B1 (de)	1997-07-30
DK0572159T3 (da)	1998-03-09
DE69312579D1 (de)	1997-09-04
EP0572159A1 (de)	1993-12-01
ES2107622T3 (es)	1997-12-01
JPH0640903A (ja)	1994-02-15
DE69312579T2 (de)	1998-03-05
AU660223B2 (en)	1995-06-15
NO931923D0 (no)	1993-05-26
CA2096556A1 (en)	1993-11-28
TW336171B (en)	1998-07-11
AU3861193A (en)	1993-12-02
ZA933469B (en)	1994-09-26
GR3025178T3 (en)	1998-02-27
NO931923L (no)	1993-11-29
US5380757A (en)	1995-01-10

Legal Events

Date	Code	Title	Description
1998-03-15	UEP	Publication of translation of european patent specification
1999-08-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
AU660223B2 (en)	1995-06-15	Fatty acid treatment
AU562938B2 (en)	1987-06-25	7, 10, 13, 16 docosatetraenoic acid composition
SE8902701D0 (sv)	1989-08-09	Fettsyrakomposition
NO940277L (no)	1994-07-28	Triglycerider og blandinger av slike
DE3875286D1 (de)	1992-11-19	Essentielle fettsaeure enthaltende zusammensetzungen.
AU554413B2 (en)	1986-08-21	Linoleic acid and essential fatty acid compositions as
ATE120954T1 (de)	1995-04-15	Verwendung von essentiellen fettsäuren zur herstellung eines arzneimittels zur behandlung von aids.
DE3485337D1 (de)	1992-01-23	Topische zubereitungen mit gehalt an teer und fettsaeuren.
DE69005062D1 (de)	1994-01-20	Fettsäuren zur Behandlung und Prävention von Hautschäden durch Radiotherapie.
ATE19855T1 (de)	1986-06-15	Pharmazeutische und diaetetische zusammensetzung.
GB9125602D0 (en)	1992-01-29	Method of preventing reocclusion of arteries